Skip to main content

Houston-Area Institutions, Companies Awarded More Than $100 Million in CPRIT Funds So Far in 2023

Published Jun 29, 2023 by Taylor Tatum

MD Anderson Cancer Center

Home to the Texas Medical Center and its world-renowned health care institutions, as well as a growing number of life sciences companies and developments, it’s no surprise that Houston-area organizations are frequent recipients of competitive health care grants, especially for cancer research. 

So far this year, Houston-area companies and institutions have received nearly $106 million in funding from the Cancer Prevention and Research Institute of Texas (CPRIT), accounting for nearly 66 percent of all CPRIT funding in 2023. The Houston region’s impressive share of funding further establishes its place as a leader in the life sciences sector. 

In 2007, Texans voted to create CPRIT, the state’s leading agency in the fight against cancer, to invest in research, create and expand life sciences infrastructure across the state, and advance and expedite breakthroughs and innovation. CPRIT is the second largest cancer research and prevention program in the world, awarding over $6 billion to Texas research institutions and organizations to date through its academic research, prevention, and product development research programs. The organization is responsible for recruiting nearly 300 top researchers to Texas and supporting the establishment, expansion, or relocation of over 50 companies to the state, creating nearly 8,000 permanent jobs in Texas in 2022. 

So far in 2023, CPRIT has awarded over 30 grants to a variety of private companies and research and academic institutions located in the Houston region, including: 

  • OncoResponse, a Seattle-based biotech company developing fully human monoclonal antibodies for the treatment of cancers that would otherwise not respond to immunotherapy. The company is moving its headquarters to Houston thanks to a $13.3 million CPRIT grant that will support a clinical study for its OR502 antibodies. 
  • 7 Hills Pharma LLC, a biotech company specializing in immunotherapy through its development of oral integrin activators that will help the body’s cells in creating a successful immune response. 7 Hills was awarded a $13.5 million grant from CPRIT to continue its work in developing treatments for melanoma patients who are resistant to immune checkpoint inhibitor (ICI) therapy. 
  • The Cell Therapy Manufacturing Center (CTMC), a joint venture between Resilience and MD Anderson Cancer Center, was awarded $9.1 million to build cell therapy manufacturing technologies that will attract future value-added biotech partnerships. CTMC plans to develop platforms and expertise to reduce manufacturing time, variability, and cost to reach patients, while also supporting innovation efforts and research knowledge. 

Top cancer researchers, academic leaders, and CEOs of CPRIT-funded private companies will convene at CPRIT’s Innovations in Cancer Prevention and Research Conference VI in Galveston in October to discuss the progress being made in cancer research, prevention, and product development at medical and academic institutions and in companies and communities across Texas.

Related News

Quality of Life

Partnership Launches Best Place for Working Parents Assessment

2/28/24
The Greater Houston Partnership has launched the Best Place for Working Parents®, an online self-assessment enabling local business leaders to determine whether their organization qualifies to earn the designation. Originating in Fort Worth in 2020, the confidential online business self-assessment allows businesses of all sizes tout innovative practices that are helping today’s working parents provide for their families, and adapt and thrive at work during extraordinary times. The assessment highlights the top 10 research-backed policies proven to benefit working parents and businesses’ bottom line. The assessment also provides a real-time dashboard of how a business fares against other businesses of like size and industry across each of the top 10 family-friendly practices in their region. While family-friendly policies have a direct impact on working parents, research shows that there is also a serious business case for being family-friendly: 83% of millennials would leave one job for another with stronger family-friendly support. Replacing an employee costs an employer six to nine months of that employee’s salary. Over 60% of working parents said child care issues have caused them to miss work. Employers lose $13 billion annually due to child care challenges faced by their workforce.    As the lead organization in the Houston region, the Partnership encourages businesses to participate in the assessment and learn more about the effectiveness of their policies. The self-assessment offers real-time designations to businesses of all sizes whose family-friendly policies qualify through a first-of-its-kind, 3-minute online self-assessment. The Best Place for Working Parents® designation for qualifying businesses can be accessed at business.bestplace4workingparents.com. View these additional resources to learn more about the assessment and why it's important.  Case Studies The Family-Friendly Initiative Participating Workplaces Gaining a Competitive Edge through Family-Friendly Policies 2023 National Trends Report “Getting Back to Work” Research Report 2024 National Summit
Read More
Economic Development

Houston's Life Sciences Sector on the Verge of a New Era

2/27/24
Houston continues to evolve as a premier destination for life sciences and biomanufacturing through a multifaceted strategy that capitalizes on its existing strengths and fosters innovation and growth.   Since its inception in 1945, the Texas Medical Center has evolved into a vast medical district spanning 5 square miles  and serving over ten million patients annually.  More than 60 institutions operate within the Texas Medical Center, serving as a catalyst for Houston’s collaborative ecosystem, with efforts like the Cell Therapy Manufacturing Center, JLABS@TMC and CUBIO. This helps set the stage for groundbreaking research and provides direct access to nearly 5,000 active clinical trials, a major boon to innovation.   Recent years have witnessed significant strides in laying a robust foundation for Houston's position as a leader in innovative life sciences and biotechnology. These efforts came into focus last month at Bisnow’s Life Sciences Evolution event, with leaders in the life sciences industry, real estate and innovation envisioning the future growth of the Houston life sciences market. Among the assets shared as advantages were access to clinical trials, business environment, workforce efforts and quality of life.   “Having access to the patient population is critical to success, especially a diverse population,” Monique Knighten, PhD of Portal Innovations said. “There’s a key benefit to have access to these clinical trials and the expertise involved, as well as living close to where the science is being developed.”   Legislative actions, such as the passage of Proposition 10 in November which provides new incentives for medical device and pharmaceutical manufacturing companies, enhances the region's competitiveness and economic prospects. Additionally, investments in workforce development, exemplified by collaborations between educational institutions and industry partners like San Jacinto College and the National Institute for Bioprocessing Research and Training (NIBRT), ensure a skilled talent pool for the future.  “The relationships with companies, colleges and high schools are integral,” Pearland EDC Vice President Brian Malone said on the panel at Bisnow discussing suburban life sciences growth. “We’ve really worked hard on that with a business retention plan to find out what type of training and what type of workers these companies need.”   Furthermore, substantial real estate investments further support life sciences research and development. TMC’s Helix Park opened in 2023 with the TMC Collaborative Building and industry research hub Dynamic One, with new tenant Houston Methodist leasing 75,800 square feet. Just north inside the Medical District, Hines’ Levit Green is now leasing nearly 300,000 square feet of purpose-built lab and office space as part of a future 53-acre district. On the northeast side of the metro, McCord’s master-planned Generation Park recently broke ground on a new Center for Biotechnology in partnership with San Jacinto College. In The Woodlands, Alexandria is developing 8800 Technology Forest Place into 325,000 square feet of Class A space.   Initiatives such as the Cancer Prevention Research Institute of Texas (CPRIT) and a thriving innovation ecosystem further reinforce the city's position at the forefront of bioscience breakthroughs and economic impact.  With strategic advantages like its top-ranked port, diverse population, and accessibility to global markets, Houston is poised to further elevate its status as a hub for life sciences innovation. As Houston continues to advance its life sciences and biotechnology sector, opportunities for collaboration and growth abound, driving progress in public health and driving the next wave of bioscience innovation.   Explore Houston's dynamic life sciences ecosystem.  
Read More

Related Events

Executive Partners